首页> 外文会议>DAE Solid State Physics Symposium >In vitro Studies of Graphene Oxide Reinforced Hydroxyapatite Nanobiocomposite on Human Erythrocytes
【24h】

In vitro Studies of Graphene Oxide Reinforced Hydroxyapatite Nanobiocomposite on Human Erythrocytes

机译:石墨烯氧化物增强羟基磷灰石纳米胶质复合物的体外研究人性红细胞

获取原文

摘要

We report the interaction of graphene oxide reinforced hydroxyapatite (GO-HAp) nanocomposites with human erythrocytes. The hemocompatibility of GO-HAp found to be superior as compared to the pristine graphene oxide. It is found that the HAp nanoparticles on GO decrease the disruption of erythrocytes by minimizing the exposure of oxygen groups to phosphatidylcholine surface of erythrocyte membrane and it enhances hemocompatibility. Further, it is also found that the graphene oxide reinforced HAp nanobiocomposite enhances the metabolic activity of osteoblasts-like cells by promoting cell proliferation.
机译:我们报道了石墨烯氧化物增强羟基磷灰石(GO-HAP)纳米复合材料与人红细胞的相互作用。与原始石墨烯氧化物相比,去HAP的血液相容性被发现优越。发现HAP纳米颗粒通过最小化红细胞膜的磷脂基胆碱表面,通过最小化氧基团的暴露而降低红细胞的破坏,并增强了血液相位性。此外,还发现,通过促进细胞增殖,石墨烯氧化物增强Hap Nap纳米肽复合材料通过促进细胞增殖而增强了成骨细胞样细胞的代谢活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号